The psychopathological impact of the SARS-CoV-2 epidemic on subjects suffering from different mental disorders: An observational retrospective study.


Journal

Psychiatry research
ISSN: 1872-7123
Titre abrégé: Psychiatry Res
Pays: Ireland
ID NLM: 7911385

Informations de publication

Date de publication:
01 2022
Historique:
received: 29 04 2021
revised: 22 11 2021
accepted: 05 12 2021
pubmed: 14 12 2021
medline: 11 1 2022
entrez: 13 12 2021
Statut: ppublish

Résumé

SARS-CoV-2 infection causes a pulmonary disease (COVID-19) which spread worldwide generating fear, anxiety, depression in the general population as well as among subjects affected by mental disorders. Little is known about which different psychopathological changes the pandemic caused among individuals affected by different psychiatric disorders, which represents the aim of the present study. Specific psychometric scales were administered at three time points: T0 as outbreak of pandemic, T1 as lockdown period, T2 as reopening. Descriptive analyses and linear regression models were performed. A total of 166 outpatients were included. Overall, psychometric scores showed a significant worsening at T1 with a mild improvement at T2. Only psychopathology in schizophrenia (SKZ) patients and obsessive-compulsive (OC) symptoms did not significantly improve at T2. Subjects affected by personality disorders (PDs) resulted to be more compromised in terms of general psychopathology than depressed and anxiety/OC ones, and showed more severe anxiety symptoms than SKZ patients. In conclusion, subjects affected by PDs require specific clinical attention during COVID-19 pandemic. Moreover, the worsening of SKZ and OC symptoms should be strictly monitored by clinicians, as these aspects did not improve with the end of lockdown measures. Further studies on larger samples are needed to confirm our results. ClinicalTrials.gov Identifier: NCT04694482.

Identifiants

pubmed: 34902818
pii: S0165-1781(21)00629-6
doi: 10.1016/j.psychres.2021.114334
pmc: PMC8664498
pii:
doi:

Banques de données

ClinicalTrials.gov
['NCT04694482']

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

114334

Informations de copyright

Copyright © 2021 Elsevier B.V. All rights reserved.

Références

Arch Gen Psychiatry. 2004 Mar;61(3):310-7
pubmed: 14993119
Schizophr Bull. 2020 Jul 8;46(4):752-757
pubmed: 32343342
Compr Psychiatry. 2008 Jan-Feb;49(1):65-9
pubmed: 18063043
Curr Opin Psychiatry. 2021 May 1;34(3):203-210
pubmed: 33587494
BJPsych Open. 2021 Jan 12;7(1):e35
pubmed: 33431109
Arch Gen Psychiatry. 1989 Nov;46(11):1006-11
pubmed: 2684084
Br J Psychiatry. 1978 Nov;133:429-35
pubmed: 728692
Iran J Psychiatry. 2018 Apr;13(2):84-93
pubmed: 29997653
J Neurol Neurosurg Psychiatry. 1960 Feb;23:56-62
pubmed: 14399272
Psychiatry Res. 2020 Dec;294:113493
pubmed: 33038789
Front Psychiatry. 2019 Oct 09;10:710
pubmed: 31649564
Int J Soc Psychiatry. 2020 Jun;66(4):317-320
pubmed: 32233719
Psychiatry Res. 2020 Sep;291:113213
pubmed: 32535508
Curr Psychiatry Rep. 2020 Nov 10;22(12):80
pubmed: 33170391
Psychiatry Res. 2020 Nov;293:113463
pubmed: 32977050
Front Psychol. 2020 Nov 17;11:586246
pubmed: 33281685
Psychiatry Clin Neurosci. 2020 Dec;74(12):660-661
pubmed: 32920936
Int J Soc Psychiatry. 2016 Feb;62(1):41-50
pubmed: 26081467
Front Psychiatry. 2020 Jul 21;11:720
pubmed: 32793008
JAMA Psychiatry. 2020 Sep 1;77(9):974-976
pubmed: 32352480
Br J Psychiatry. 1979 Apr;134:382-9
pubmed: 444788
Lancet Psychiatry. 2020 Sep;7(9):813-824
pubmed: 32682460
Schizophr Bull. 1987;13(2):261-76
pubmed: 3616518
Early Interv Psychiatry. 2021 Oct;15(5):1136-1145
pubmed: 33058435
J Affect Disord. 2021 May 1;286:296-300
pubmed: 33756307
J Affect Disord. 2020 Aug 1;273:375-379
pubmed: 32560931
Int J Environ Res Public Health. 2020 Jul 02;17(13):
pubmed: 32630821
Int J Environ Res Public Health. 2020 Jun 10;17(11):
pubmed: 32532077
Int Clin Psychopharmacol. 1996 Jun;11 Suppl 3:89-95
pubmed: 8923116
Br J Med Psychol. 1959;32(1):50-5
pubmed: 13638508
Int J Soc Psychiatry. 2022 Feb;68(1):129-133
pubmed: 33295245
Brain Behav Immun. 2020 Jul;87:100-106
pubmed: 32353518
Arch Gen Psychiatry. 1989 Nov;46(11):1012-6
pubmed: 2510699
Ir J Psychol Med. 2020 Dec;37(4):283-290
pubmed: 32368994
Lancet. 2020 Mar 14;395(10227):912-920
pubmed: 32112714
Schizophr Res. 2020 Aug;222:3-5
pubmed: 32473931
Schizophr Res Cogn. 2014 Mar;1(1):e1-e9
pubmed: 25254156

Auteurs

Alice Caldiroli (A)

Psychiatric Department, Azienda Socio Sanitaria Territoriale Monza, Via G.B. Pergolesi 33 MB, Monza, Italy. Electronic address: a.caldiroli@asst-monza.it.

Enrico Capuzzi (E)

Psychiatric Department, Azienda Socio Sanitaria Territoriale Monza, Via G.B. Pergolesi 33 MB, Monza, Italy.

Agnese Tringali (A)

Department of Medicine and Surgery, University of Milan Bicocca, via Cadore 38 MB, Monza 20900, Italy.

Ilaria Tagliabue (I)

Department of Medicine and Surgery, University of Milan Bicocca, via Cadore 38 MB, Monza 20900, Italy.

Marco Turco (M)

Department of Medicine and Surgery, University of Milan Bicocca, via Cadore 38 MB, Monza 20900, Italy.

Andrea Fortunato (A)

Department of Medicine and Surgery, University of Milan Bicocca, via Cadore 38 MB, Monza 20900, Italy.

Matteo Sibilla (M)

Department of Medicine and Surgery, University of Milan Bicocca, via Cadore 38 MB, Monza 20900, Italy.

Caterina Montana (C)

Department of Medicine and Surgery, University of Milan Bicocca, via Cadore 38 MB, Monza 20900, Italy.

Laura Maggioni (L)

Department of Medicine and Surgery, University of Milan Bicocca, via Cadore 38 MB, Monza 20900, Italy.

Cristian Pellicioli (C)

Department of Medicine and Surgery, University of Milan Bicocca, via Cadore 38 MB, Monza 20900, Italy.

Matteo Marcatili (M)

Psychiatric Department, Azienda Socio Sanitaria Territoriale Monza, Via G.B. Pergolesi 33 MB, Monza, Italy.

Roberto Nava (R)

Psychiatric Department, Azienda Socio Sanitaria Territoriale Monza, Via G.B. Pergolesi 33 MB, Monza, Italy.

Giovanna Crespi (G)

Psychiatric Department, Azienda Socio Sanitaria Territoriale Monza, Via G.B. Pergolesi 33 MB, Monza, Italy.

Fabrizia Colmegna (F)

Psychiatric Department, Azienda Socio Sanitaria Territoriale Monza, Via G.B. Pergolesi 33 MB, Monza, Italy.

Massimiliano Buoli (M)

Department of Neurosciences and Mental Health, Fondazione IRCCS Ca'Granda Ospedale Maggiore Policlinico, Via F. Sforza 35, Milan 20122, Italy; Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.

Massimo Clerici (M)

Psychiatric Department, Azienda Socio Sanitaria Territoriale Monza, Via G.B. Pergolesi 33 MB, Monza, Italy; Department of Medicine and Surgery, University of Milan Bicocca, via Cadore 38 MB, Monza 20900, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH